State of the art in restless legs syndro
โ
Wolfgang H. Oertel; Claudia Trenkwalder; Marco Zucconi; Heike Benes; Diego Garci
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 115 KB
๐ 1 views
Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigot